El lado oscuro de la DES Dr. Alexandre Abizaid y Dr. Jean Fajadet

More articles by this author

Perspectivas sobre el stent intravascular al final del camino Dr. Julio Palmaz

Perspectivas sobre el stent intravascular al final del camino Dr. Julio Palmaz

¿Qué DES actual no debe faltar en mi lista? Dr. Eduardo Sousa

¿Qué DES actual no debe faltar en mi lista? Dr. Eduardo Sousa

PFO Closure: Indications, Tecniques & Outcome Ziyad M. Hijazi

PFO Closure: Indications, Tecniques & Outcome Ziyad M. Hijazi

Manejo de la enfermedad de tronco coronario izquierdo y múltiples vasos: No debemos ignorar el contexto histórico Dr. Valentín Fuster

Manejo de la enfermedad de tronco coronario izquierdo y múltiples vasos: No debemos ignorar el contexto histórico Dr. Valentín Fuster

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Dynamic Coronary Roadmap: does it really help reduce contrast use?

Contrast-induced nephropathy remains a relevant complication of percutaneous coronary interventions (PCI), particularly in patients with multiple comorbidities and complex coronary anatomies. Dynamic Coronary Roadmap...

Endoleaks after endovascular repair of complex aortic aneurysms: always reintervene or monitor with CTA?

Endovascular repair of thoracoabdominal aneurysms requiring sealing above the renal arteries, with preservation of visceral vessels using fenestrated and/or branched devices (F/B-EVAR), has become...

Is it safe to use negative chronotropic drugs early after TAVI?

TAVI is associated with a relevant incidence of conduction system disturbances and the development of atrioventricular block that may require permanent pacemaker implantation. Many...